176 related articles for article (PubMed ID: 35440807)
1. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21.
Wang H; Qi Y; Lan Z; Liu Q; Xu J; Zhu M; Yang T; Shi R; Gao S; Liang G
Gene Ther; 2023 Feb; 30(1-2):88-100. PubMed ID: 35440807
[TBL] [Abstract][Full Text] [Related]
2. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
4. Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma.
Xu W; Chen Y; Zhang Z; Jiang Y; Wang Z
Med Oncol; 2023 Jul; 40(8):221. PubMed ID: 37402056
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.
Yan J; Shi L; Lin S; Li Y
Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
Cheng J; Yang Q; Han X; Wang H; Wu K; Zhao H
Bioengineered; 2022 Apr; 13(4):10244-10257. PubMed ID: 35435118
[TBL] [Abstract][Full Text] [Related]
8. Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression.
Tang B; Zhang Q; Liu K; Huang Y
Bioengineered; 2022 May; 13(5):13829-13848. PubMed ID: 35703190
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
[TBL] [Abstract][Full Text] [Related]
10. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
12. CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway.
Zheng S; Shen T; Liu Q; Liu T; Tuerxun A; Zhang Q; Yang L; Han X; Lu X
J Cell Physiol; 2021 Jul; 236(7):5373-5386. PubMed ID: 33368292
[TBL] [Abstract][Full Text] [Related]
13. Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma.
Qiu R; Wang W; Li J; Wang Y
Mol Biol Rep; 2022 Jul; 49(7):6633-6645. PubMed ID: 35301651
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
He Z; Li W; Zheng T; Liu D; Zhao S
J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
[TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
16. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
18. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axis.
Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma.
Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z
Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
